- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on BRAFV600E Melanoma Patients in United States
Total 3134 results
-
National Cancer Institute (NCI)CompletedPrecancerous Condition | Stage II Melanoma | Stage 0 Melanoma | Stage I MelanomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingMelanoma | Advanced MelanomaUnited States
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Duke UniversityCompletedUnresectable MelanomaUnited States
-
Hoag Memorial Hospital PresbyterianCompletedMetastatic MelanomaUnited States
-
Eisai Inc.Completed
-
Duke UniversityTerminatedMetastatic MelanomaUnited States
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
California Pacific Medical Center Research InstituteCompletedMetastatic MelanomaUnited States
-
Millennium Pharmaceuticals, Inc.Completed
-
NewLink Genetics CorporationCompletedMetastatic Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbCompleted
-
Abramson Cancer Center at Penn MedicineNovartis PharmaceuticalsTerminated
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron PharmaceuticalsCompletedUveal MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterActive, not recruitingMetastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMetastatic MelanomaUnited States
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
University of California, IrvineTerminatedMetastatic MelanomaUnited States
-
John P. FruehaufBayerCompletedMetastatic MelanomaUnited States
-
American Regent, Inc.Completed
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Western Regional Medical CenterWithdrawnMetastatic MelanomaUnited States
-
John KirkwoodNational Cancer Institute (NCI); National Institutes of Health (NIH)Terminated
-
National Human Genome Research Institute (NHGRI)Completed
-
Beth Israel Deaconess Medical CenterGenzyme, a Sanofi CompanyCompletedMetastatic MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
University of ChicagoCompletedMetastatic MelanomaUnited States
-
Providence Health & ServicesWithdrawn
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Memorial Sloan Kettering Cancer CenterYale University; University of New MexicoCompleted
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted
-
NeoPlas InnovationWithdrawnMelanoma | Malignant MelanomaUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
University of ChicagoMerck Sharp & Dohme LLC; Evelo Biosciences, Inc.Suspended
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic MelanomaMetastatic MelanomaUnited States
-
Abramson Cancer Center at Penn MedicineImaginAb, Inc.Enrolling by invitation
-
National Cancer Institute (NCI)CompletedMetastatic MelanomaUnited States
-
Emory UniversityWithdrawn
-
University of LouisvilleJames Graham Brown Cancer CenterCompletedMetastatic MelanomaUnited States
-
University of LouisvilleJames Graham Brown Cancer CenterTerminatedMetastatic MelanomaUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawn
-
University of Texas Southwestern Medical CenterWithdrawnMelanoma | Metastatic MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted